{"id":670,"date":"2015-06-09T17:09:17","date_gmt":"2015-06-09T21:09:17","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=670"},"modified":"2015-06-09T17:09:17","modified_gmt":"2015-06-09T21:09:17","slug":"secondaries-announced-6-9-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-6-9-2015\/","title":{"rendered":"Secondaries announced 6.9.2015"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n

Company:\tIgnyta, Inc.
\nSymbol:\tRXDX
\nPrice:\t\tLast trade $18.08
\nTrade Date:\t6\/10
\nShares:\t\t4.1 million
\nUnderwriter(s)\tCredit Suisse, Jefferies, Leerink Partners, Piper Jaffray
\nCo Manager(s)\tCantor Fitzgerald, Ladenburg Thalmann
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tHeron Therapeutics
\nSymbol:\tHRTX
\nPrice:\t\tLast trade $26.07
\nTrade Date:\t6\/10
\nShares:\t\t3.83 million
\nUnderwriter(s)\tJefferies, Leerink Partners, Cowen & Co.
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tGulfport Energy
\nSymbol:\tGPOR
\nPrice:\t\tLast trade $45.37
\nTrade Date:\t6\/10
\nShares:\t\t10 million
\nUnderwriter(s)\tCredit Suisse
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tCynapsus Therapeutics
\nSymbol:\tCYNA
\nPrice:\t\tLast trade $14.18
\nDescription:\tCurrently listed on the Toronto Stock Exchange under the symbol ‘CTH’.
\nTrade Date:\t6\/18
\nShares:\t\t4.5 million
\nUnderwriter(s)\tBofA Merrill Lynch, Nomura
\nCo Manager(s)\tNoble Life Science Partners
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tScorpio Bulkers
\nSymbol:\tSALT
\nPrice:\t\tLast trade $2.17
\nTrade Date:\t6\/11
\nShares:\t\t92 million
\nUnderwriter(s)\tDeutsche Bank Securities, Clarksons Platou Securities AS, Evercore ISI, Stifel
\nCo Manager(s)\tABN AMRO, Credit Agricole CIB, Clarksons Platou Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tChimerix, Inc.
\nSymbol:\tCMRX
\nPrice:\t\tLast trade $41.66
\nTrade Date:\t6\/11
\nShares:\t\t3.6 million
\nUnderwriter(s)\tMorgan Stanley, J.P. Morgan
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tNew Residential Investment Corp.
\nSymbol:\tNRZ
\nPrice:\t\tLast trade $16.63
\nTrade Date:\t6\/10
\nShares:\t\t31.5 million
\nUnderwriter(s)\tBofA Merrill Lynch, Citigroup, J.P. Morgan
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Ignyta, Inc. Symbol: RXDX Price: Last trade $18.08 Trade Date: 6\/10 Shares: 4.1 million Underwriter(s) Credit Suisse, Jefferies, Leerink Partners, Piper[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[464,462,317,461,296,460,463],"class_list":["post-670","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cmrx","tag-cyna","tag-gpor","tag-hrtx","tag-nrz","tag-rxdx","tag-salt"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=670"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/670\/revisions"}],"predecessor-version":[{"id":671,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/670\/revisions\/671"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}